Q3 2026
Q3 US comparable-sales growth
Sep 13.8%
3.3–4.9 range
Derived from public YES prices · observed Sep 1, 2026

WMT
PRICE + EARNINGS
WMT · daily price and volumeQ3 2026
3.3–4.9 range
Derived from public YES prices · observed Sep 1, 2026
Q2 2027 · Aug 20, 2026
Competition carried the heaviest trading on the board at 40¢ and resolved No. Prescription, at 35¢, was the only contested word that landed.
$0.74 expected
versus consensus
Prescription
Competition / Competitor
EARNINGS WORDS
96% before the call
8:02 AM ET · +3 min